Ketamine: An old medication with newly discovered actions in pain and breathing regulation

Written by

Professor Dahan studies the benefits of the drug ketamine.

Pain that lasts longer than the expected period of healing is tormenting a significant percentage of the population and is the leading cause of disability worldwide. Although medications are available to control it, its management often involves trial and error, especially in cases where specific nerve damage cannot be found. Professor Albert Dahan at the Leiden University Medical Center in […]

Awakn: Welcoming a new era of psychedelic-assisted therapy

Written by

Research Outreach interviews Ben Sessa, co-founder and Head of Psychedelic medicine at Awakn Life Sciences about his academic research and work with psychedelic-assisted therapy using ketamine.

Dr Ben Sessa is a psychiatrist, researcher, writer, and Co-founder and Head of Psychedelic Medicine at Awakn Life Sciences. His academic research coupled with his therapeutic practice have yielded vital insights into the safety and efficacy of psychedelic-assisted therapy. Now, practicing with the biotechnology company Awakn Life Sciences, he is working to increase the availability of these revolutionary treatments. As […]